Ceres, Inc.
USPTO PatentsView assignee record - 126 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Ceres ranks #3,005 of 49,997 tracked US assignees by granted-patent volume, with 126 patents across 16 technology areas.
- #3,005
- of 49,997 US assignees by volume
- Top 23%
- by Innovation Score (45.4/100)
- 11.6
- avg claims per patent
- +103%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3005 · US Corporation #3,005 · 126 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MID 126 grants
- TOP-DECILE #3,005/49,997
- PHOTO-FINISH Abb Vie Deutschland…
- CPC-FOCUS C12N · 16 areas
- INNOV-PAR 45.4/100
- CLAIMS-PAR 11.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +103% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Abb Vie Deutschland Gmbh & Co. KG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ceres’s 45.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ceres
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Broan-NuTone · near
Broan-NuTone · near
45 score
- Ceres · this assignee
Ceres · this assignee
45 score
- Good Tree Internatio… · near
Good Tree Internatio… · near
45 score
- PureCircle Sdn Bhd · near
PureCircle Sdn Bhd · near
45 score
- Restful Pump · near
Restful Pump · near
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ceres's Innovation Score is 45.4/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ceres?
Each dot is one of Ceres’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ceres’s own 11.6 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Ceres's grants concentrate
Ceres, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 98.4% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2023 (24 grants) versus a trough of 3 in 2016. By volume, Ceres sits between Whitehead Institute For Biomedical Research and Deutsche Post AG.
Ceres's three-year grant acceleration
From 2019–2021 to 2022–2024, Ceres, Inc. moved from 42 to 48 grants (1.14x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #883. See the growth leaderboard.
Who files at Ceres's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Whitehead Institu…
Whitehead Institute For Biomedical Research
127 patents
- Wyeth
Wyeth, LLC
127 patents
- Abb Vie Deutschla…
Abb Vie Deutschland Gmbh & Co. KG
126 patents
- Chatsworth Produc…
Chatsworth Products, Inc.
126 patents
- Cobra Golf Incorp…
Cobra Golf Incorporated
126 patents
- Dexin
Dexin Corporation
126 patents
- Dena
DeNA Co., Ltd.
126 patents
- Deutsche Post
Deutsche Post AG
126 patents
- Ceres ◀
Ceres, Inc.
126 patents
What this shows Ceres holds 126 patents at rank #3,006, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ceres
By rank, the assignees closest to #3,006 in granted patent volume.
- Whitehead Institute For Biomedical Research #3,002 · 127 patents
- Wyeth, LLC #3,003 · 127 patents
- Abb Vie Deutschland Gmbh & Co. KG #3,004 · 126 patents
- Chatsworth Products, Inc. #3,005 · 126 patents
- Cobra Golf Incorporated #3,007 · 126 patents
- Dexin Corporation #3,008 · 126 patents
- DeNA Co., Ltd. #3,009 · 126 patents
- Deutsche Post AG #3,010 · 126 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Ceres's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Ceres, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Ceres ranks #69 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (45 here).
Similar claim depth
Nearest assignees by average claims per patent (11.6 here).
Ceres's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 23% higher than 77% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 5.6% |
| 2016 | 3 | 2.4% |
| 2017 | 9 | 7.1% |
| 2018 | 9 | 7.1% |
| 2019 | 11 | 8.7% |
| 2020 | 14 | 11.1% |
| 2021 | 17 | 13.5% |
| 2022 | 12 | 9.5% |
| 2023 | 24 | 19.0% |
| 2024 | 12 | 9.5% |
| 2025partial year | 8 | 6.3% |
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ceres, Inc.'s patent record in context - here's where to go next.
- Ceres, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 98.4% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #3,005 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ceres, Inc. against Whitehead Institute For Biomedical Research, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.